pharmacopsychiatry
130595
EN
DE
Home
Produkte
Zeitschriften
Bücher
Buchreihen
Service
Service für Bibliotheken
Hilfe
Kontakt
Portal
Pharmacopsychiatry
Volltextsuche
Volltextsuche
Autorensuche
Titelsuche
DOI-Suche
Metadatensuche
Zeitschrift
Über diese Zeitschrift
Herausgeber
Informationen zur DFG-Nationallizenz
Impressum
X
Autor*innen
Autorenhinweise
Manuskript einreichen
Abonnement
Ihr Abonnement: Kontakt & Information
Lizenzen: Kontaktpartner Institutionen
AGNP
Offizielles Organ der Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie
Collections
Pharmacopsychiatry Women
About Women in Medicine
Open Access
nicht eingeloggt
Login
Benutzername oder E-Mail-Adresse:
Passwort:
Zugangsdaten vergessen?
Neu registrieren
OpenAthens/Shibboleth Login
Warenkorb
Jahre (Archiv)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
Ausgaben
Aktuelle Ausgabe
Kostenlose Probeausgabe (01/2024)
Ähnliche Zeitschriften
Drug Research
Planta Medica
PiD - Psychotherapie im Dialog
Bücher zum Thema
Psychiatrie, Psychotherapie, Psychosomatik
23. Symposium of the AGNP
Abstracts (HTML)
Autorenliste
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Abel, A.
FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain
Achenbach, U.
New scales for measuremant of anxiety in a study with hydroxyzine for patients with generalized anxiety disorder (GAS)
Ackenheil, M.
Different protein expression levels after antidepressant treatment on EBV cells of depressed patients
Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease
Ackl, N.
Evaluation of 1H-MRS as diagnostic marker for mild cognitive impairment and dementia
Adena, S. M.
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
The effects of RS-86 on sleep with respect to depression and HLA-type
Adler, L.
Efficacy and safety of atomoxetine in adults with attention deficit/hyperactivity disorder
Adli, M.
Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression
Agelink, M.
Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders?
Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone
Aicher, S.
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Ajdacic, V.
A longitudinal syndrome-oriented approach to phenotypic heterogeneity
Akkan, R.
Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration
Albrecht, N.
Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?
The significance of non-REM sleep for memory processes in elderly subjects
Albus, M.
D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate
Aldenhoff, J. B.
Changes in CREB-phosphorylation during recovery from major depression: Findings in patients exclusively treated with psychotherapy (IPT)
Antidepressants increase CREB-phosphorylation via the 5-HT(1A)-receptor
Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity
Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease
Modulation of sleep: A new approach of treating memory impairment in schizophrenia?
Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease
Novel object presentation affects sleep-wake behavior in rats
Perinatal, subchronic NMDA receptor antagonism attenuates behavior from childhood to adulthood in rats
Neurotrophic factors and the regulation of CREB as a marker and putative predictor of treatment response in major depression
A new concept for crisis management in borderline patients
Alexander, G. E.
Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry
Alexson, S.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Alling, C.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Alt, A.
Leptin levels of alcohol abstainers and detoxification patients are not different
Altshuler, L.
Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study
Amann, B.
EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Amberg, R.
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Anghelescu, I.
Clonidine for hypernoradrenergic symptoms In patients with borderline personality disorder
From mouse models to human behavior: Testing candidate genes for alcoholism
New antiepileptic drugs (AED) and atypical antipsychotics (AAP) as mood stabilizers
The NSAID rofecoxib reduces subjective cognitive impairment associated with ECT
Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis
Angst, J.
How to assess the onset of antidepressant effect: Empirical data on 2788 patients
Time course of response to antidepressant drug treatment: Are there gender differences?
A longitudinal syndrome-oriented approach to phenotypic heterogeneity
Annen, B.
Predictive value of sleep EEG markers in long-term course of depression
Antonijevic, I. A.
Gender differences in sleep endocrine regulation following administration of growth-hormone releasing hormone (GHRH) – relevance for the pathophysiology of major depression
Arlt, J.
Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide
Arolt, V.
High basal prolactin values predict response to reboxetine treatment in major depression
The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
Visually-evoked event-related potentials and oral citalopram challenge test
Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B
Aschenbrenner, S.
The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression
Auer, D. P.
Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla
Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium
Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study
Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study
Evaluation of 1H-MRS as diagnostic marker for mild cognitive impairment and dementia
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study
Aust, C.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Auwärter, A.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Bachus, R.
Saccadic eye movements and cognitive performance in schizophrenic patients treated with clozapine or flupentixol
Bäcker, A.
Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm
Baethge, C.
Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects
Baghai, T. C.
Influence of mirtazapine on salivary cortisol in depressed patients
Different protein expression levels after antidepressant treatment on EBV cells of depressed patients
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Gender influence on pharmacogenetic prediction of antidepressive efficacy
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
Bahra, R.
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Baier, C.
Restaurative therapy for Parkinson’s disease
Bajbouj, M.
EEG source localization during postictal delirium following electroconvulsive therapy
Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability
Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing
Altered cortical inhibition after electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)
Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis
Banac, S.
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Bandelow, B.
Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration
Barbosa, E.
Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia
Barbosa, N. R.
Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment
Barnas, C.
The influence of somatic conditions on benzodiazepine long-term use
Bartels, M.
Treatment of tics in Tourette’s syndrome with aripiprazole
Bartenstein, P.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography
Barth, U.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Bartl, C.
Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants
Bauer, A.
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study
Bauer, M.
Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study
Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression
Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients
Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects
Baumann, B.
Effects of antidepressants in postmortem and neuroimaging studies
Baumann, P.
Influence of metabolic processes on course and treatment of opioid-dependence
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Interactions between somatic and psychotropic drugs: pharmacokinetic and pharmacodynamic consequences.
Baumgart, U.
Rhabdomyolysis associated with olanzapine monotherapy – A case report
Baumgartner, S.
Alterations of glucose metabolism under treatment with atypical antipsychotics
Bayerlein, K.
Leptin plasma levels and craving data during alcohol withdrawal
Craving differs with alcoholic beverages
Bechtel, G.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Leptin levels of alcohol abstainers and detoxification patients are not different
Becker, A.
Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results
Kindling alters rewarding effects of ethanol, morphine and cocaine
Behl, C.
Antioxidants and hormones: Implications for neurodgenerative disorders and aging
Beissbarth, T.
cDNA arrays analyses in an animal model for psychosis-related traits
Bender, S.
Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP
The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram
Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program
Benninghoff, J.
The serotonergic receptor 2C subtype (5-HT2C) regulates survival and proliferation of adult neural stem cells (ANSC) derived from mouse hippocampus
Berendt, F.
Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease
Berg, T.
Interferon-alpha treatment and serotonergic dysfunction
Bergemann, N.
Therapeutic drug monitoring data: No influence of amisulpride on clozapine plasma concentration
Berger, C.
Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy
Berger, M.
Transient narcolepsy-cataplexy-syndrome after discontinuation of the antidepressant venlafaxine
Modulation of neuropeptidergic circuits
Substance P and substance P antagonists in the pathology and treatment of affective disorders
Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells
Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P
Bergmann, A.
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease
Berman, S. M.
Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study
Bernhardt, K.
A new concept for crisis management in borderline patients
Bernstein, H. G.
Effects of antidepressants in postmortem and neuroimaging studies
The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study
Bertling, R.
Effectiveness of music therapy on pain reduction and psychopharmacotherapy
Bielau, H.
Effects of antidepressants in postmortem and neuroimaging studies
Bilkei-Gorzo, A.
New insights into the role of the opioid system as mediator of drug addiction by studies in transgenic mice
Binder, E.
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
Binder, E. B.
ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders
Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
Prediction of response to antidepressant monotherapy
Is there a genetic continuum between anxiety and depression?
Birg, I. N.
Validation of a genetic mouse model for anxiety and comorbid depression
Analysis of cerebrospinal fluid of depressed patients
Birkenbach-Holdschuh, T.
A new measure of the dopamine challenge by bromocriptine for testing personality
Birkmann, S.
Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders
Blaha, L.
Predicting successful job performance of schizophrenics after discharge from hospital
Bleich, S.
CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Leptin plasma levels and craving data during alcohol withdrawal
Craving differs with alcoholic beverages
Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration
Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy
Blennow, K.
A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia
Block, W.
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence
Bodner, T.
Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?
Boerner, R. J.
Naturalistic follow-up study of pharmacologic treated patients with anxiety disorders
New scales for measuremant of anxiety in a study with hydroxyzine for patients with generalized anxiety disorder (GAS)
Bogerts, B.
Different inhibitory mechanism in BALB-c and CPB/K mice using the prepulse inhibition paradigm – An animal model for schizophrenia?
Effects of antidepressants in postmortem and neuroimaging studies
The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study
Boigs, M.
Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity
Modulation of sleep: A new approach of treating memory impairment in schizophrenia?
Bokde, A. L. W.
Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Neural representation of cognitive changes within the visual system in the AD brain
Bölte, S.
The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects
Bondy, B.
Different protein expression levels after antidepressant treatment on EBV cells of depressed patients
Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Gender influence on pharmacogenetic prediction of antidepressive efficacy
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene
Is there a common basis between psychiatric and somatic diseases
Bonert, A.
Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway
Bopp, G.
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence
Borgwardt, S.
Cognitive function and psychomotor performance in schizophrenic patients
Born, C.
Neural representation of cognitive changes within the visual system in the AD brain
Bottino, C. M. C.
Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex
Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment
Bottlender, R.
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Bozkurt, B.
Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings
Brand, S.
Predictive value of sleep EEG markers in long-term course of depression
Braun, H. A.
Computational biology of sensitization: Pharmacologically- relevant amplification mechanisms
Braun, S.
Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity
Modulation of sleep: A new approach of treating memory impairment in schizophrenia?
Braus, D.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Braus, D. F.
Relapse and gender specific activation of the striatum in alcohol dependent patients
Brettschneider, S.
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease
Breu, J.
Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides
Brockmöller, J.
Pharmacogenetics based therapeutic recommendations in antidepressant drug therapy
Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients
Bronisch, T.
High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression
Brückmann, H.
Differences in cortical activation by a working memory task after substitution of atypical neuroleptics
Brunner, E.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Brunner, H.
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression
Brunner, J.
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression
Prediction of response to antidepressant monotherapy
Brunnmeier, M.
Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity
Bschor, T.
Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects
Bublak, P.
A new diagnostic tool for measuring attentional components in patients with depression
Buchholz, H. G.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography
Bunck, M.
Validation of a genetic mouse model for anxiety and comorbid depression
Bürger, K.
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease
Burgmair, W.
50 years of chlorpromazine – Serendipity or necessity
Burtscheidt, W.
Alcohol-craving: Therapeutic effects using fMRI
Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal
Bymaster, F.
Pharmacologic properties of atomoxetine: a novel treatment for attention deficit/hyperactivity disorder
Camargo, C. P.
Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia
Cannich, A.
The roles of the endogenous cannabinoid system in learning and memory in mice
Carson, W.
Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia
Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia
Efficacy of aripiprazole in the treatment of mania
Cascorbi, I.
The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis
IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis
Castro, C. C.
Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia
Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex
Cerri, G. G.
Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia
Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex
Cetin, T.
Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia
Choma, M. E.
Temporal lobe structures by magnetic resonance in schizophrenic patients
Cohrs, S.
Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects
Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy
Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea
Colla, M.
Hippocampal volume reduction and HPA-system activity in major depression
Cordes, J.
Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal
Cumming, P.
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography
Czekalla, J.
Antipsychotic treatment in schizophrenic patients. 6-month data of the 3-year European observational study of health outcomes (SOHO)
Czisch, M.
Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study
Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study
Członkowska, A.
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone
Członkowski, A.
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone
Dahmen, N.
An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia
Association study of SNPs in G72 and DAAO in schizophrenia
Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia
Dalal, M. A.
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects
Dallinger, P.
Gender effects in olanzapine metabolism
Dames, P.
cDNA arrays analyses in an animal model for psychosis-related traits
Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia
Dammann, G.
Leptin levels of alcohol abstainers and detoxification patients are not different
Daniels, C.
Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease
Danker-Hopfe, H.
Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability
Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?
The significance of non-REM sleep for memory processes in elderly subjects
Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients
Danos, P.
The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study
Däubener, W.
Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings
Daumann, J.
Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies
Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users
Degner, D.
Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP
Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration
Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program
Deiml, T.
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Gender influence on pharmacogenetic prediction of antidepressive efficacy
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
de Jonge, S.
Different protein expression levels after antidepressant treatment on EBV cells of depressed patients
Delini-Stula, A.
Ginkgo biloba in the treatment of antidepressant-induced sexual dysfunction: The results of the Swiss exploratory study in depressed patients
Dettling, M.
The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis
Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome
IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis
Deuschl, G.
Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease
Deuschle, M.
Antidepressive treatment with amitriptyline and paroxetine: Effects on saliva cortisol concentrations
Circadian blood pressure regulation in hospitalized depressed patients and non-depressed comparison subjects
Steroid synthesis inhibition with ketoconazole and its effect upon the regulation of the hypothalamus-pituitary-adrenal system in healthy humans
Serum and cerebrospinal fluid concentration of Substance P before and after treatment of depressed patients
Reversible pitch perception shift caused by trimipramine
Lipid metabolism and insulin resistance in depressed patients: Significance of weight, hypercortisolemia and antidepressant treatment
Hippocampal volume reduction and HPA-system activity in major depression
Deussing, J.
Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress
Dielentheis, T. F.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Dierkes, J.
Leptin levels of alcohol abstainers and detoxification patients are not different
Dierks, T.
Pharmaco-EEG-monitoring predicts antipsychotic efficacy of atypical antipsychotic drugs
Dietrich, I.
A functional SNP (V158M) in the COMT gene is associated with aggressive personality traits
Dittmann, R. W.
Efficacy and safety of atomoxetine in adults with attention deficit/hyperactivity disorder
Pharmacologic properties of atomoxetine: a novel treatment for attention deficit/hyperactivity disorder
Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study
Dobmeier, M.
Subjective response to psychotropic drugs in psychiatric in-patients
Gender effects in olanzapine metabolism
Dobmeier, P.
Dose related frequency of EPMS in patients treated with flupentixol decanoate versus risperidone
Dobrowolny, H.
Different inhibitory mechanism in BALB-c and CPB/K mice using the prepulse inhibition paradigm – An animal model for schizophrenia?
Döhnel, K.
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses
Dong, W.
Neural representation of cognitive changes within the visual system in the AD brain
Dong-Si, T.
Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia
Dragicevic, A.
Therapeutic drug monitoring (TDM) of quetiapine
Costs and effectiveness of therapeutic drug monitoring in psychiatry
Dresel, S.
Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients
Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics
Droste, S.
Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress
Eap, C. B.
Influence of metabolic processes on course and treatment of opioid-dependence
Interactions between somatic and psychotropic drugs: pharmacokinetic and pharmacodynamic consequences.
Ebenbichler, C.
Alterations of glucose metabolism under treatment with atypical antipsychotics
Ebinger, M.
Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls
Results of routine CSF analysis of 1000 psychiatric patients
Ebrecht, M.
Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia
Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia
Efficacy of aripiprazole in the treatment of mania
Eckermann, G.
Drug interactions in elderly patients
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Eckert, A.
Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway
Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner
Eckert, K.
The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study
Edlinger, M.
Alterations of glucose metabolism under treatment with atypical antipsychotics
Ehrenreich, H.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Neuroprotection in neuropsychiatric disease
Eich, D.
A longitudinal syndrome-oriented approach to phenotypic heterogeneity
Eichhammer, P.
The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression
Cortical excitability in neuroleptic-naive first-episode schizophrenic patients
Cortical excitability in patients with adult ADHD
Gender effects in olanzapine metabolism
High-frequency transcranial magnetic stimulation in schizophrenia
High-frequency transcranial magnetic stimulation decreases cigarette smoking
Eichinger, M.
Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital
Eichler, O.
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence
Eisensamer, B.
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Modulation of ligand-gated ion channels by antidepressants
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
Ekrod, K.
Gabapentin as a mood stabiliser in the treatment of alcoholism-SAD-comorbidity
Ella, R.
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Gender influence on pharmacogenetic prediction of antidepressive efficacy
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
Emir, B.
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Engel, R. R.
The repeatable battery for the assessment of neuropsychological status (BRANS) – A useful tool in neuropsychiatry?
Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP
Systematic screen of serotonergic genes in suicidal behaviour
Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program
Erb, M.
Pharmako-FMRT in Alzheimers dementia
Erdag, S.
A psychoeducative-cognitive group setting for patients with schizophrenia: Making use of newly gained neuroplasticity
Erfurth, A.
High basal prolactin values predict response to reboxetine treatment in major depression
The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
Visually-evoked event-related potentials and oral citalopram challenge test
Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B
Erhardt, A.
Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal
Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism
Is there a genetic continuum between anxiety and depression?
Eschenhagen, T.
CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants
Eser, D.
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Gender influence on pharmacogenetic prediction of antidepressive efficacy
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
Evans, A. C.
Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Evers, S.
The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
Visually-evoked event-related potentials and oral citalopram challenge test
Falkai, P.
The impact of pharmacotherapy on the spectra in magnetic resonance spectroscopy
The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study
Faltraco, F.
Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease
A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia
Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease
Neural representation of cognitive changes within the visual system in the AD brain
Fehr, C.
From mouse models to human behavior: Testing candidate genes for alcoholism
Fehsel, K.
In vitro, inhibition of oxidative stress prevents clozapine-induced apoptosis in neutrophils
Increased sensitivity of isolated CD34+ cells towards clozapine-treatment
Fellgiebel, A.
Therapeutic drug monitoring (TDM) of donepezil
Ferrari, U.
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Fiebich, B. L.
Modulation of neuropeptidergic circuits
Substance P and substance P antagonists in the pathology and treatment of affective disorders
Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells
Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P
Fink, H.
Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats
Finke, K.
A new diagnostic tool for measuring attentional components in patients with depression
Fischer, C. J.
A new model for assessment of mechanisms of behavior control and impulsivity
Fischer-Barnicol, D.
Benefit of modern antipsychotics still withheld from forensic patients
Perazine – the atypical side of an conventional antipsychotic
Fischermann, T.
Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies
Fischer-Schulz, C.
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease
Fleischhacker, W. W.
Alterations of glucose metabolism under treatment with atypical antipsychotics
Flor, H.
Relapse and gender specific activation of the striatum in alcohol dependent patients
Folkerts, M.
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Forlenza, O. V.
Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex
Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment
Phospholipase a2 activity in rat embryonic brain and in primary cultures of cortical neurons
Forster, S.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Leptin levels of alcohol abstainers and detoxification patients are not different
Förstl, H.
D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate
Franc, D.
Results of routine CSF analysis of 1000 psychiatric patients
Frank, E.
Cortical excitability in patients with adult ADHD
Franke, E.
Interferon-alpha treatment and serotonergic dysfunction
Franke, L.
Cognitive function and psychomotor performance in schizophrenic patients
Franz, M.
Subjective reactions to neuroleptic treatment: Prediction of compliance?
Freudenmann, R. W.
Psychopharmacological treatment from the patients’ perspective. A computer-based automatic interview system
Frick, A.
Therapeutic drug monitoring data: No influence of amisulpride on clozapine plasma concentration
Frieboes, R. M.
Gender differences in sleep endocrine regulation following administration of growth-hormone releasing hormone (GHRH) – relevance for the pathophysiology of major depression
Friege, L.
Modulation of sleep: A new approach of treating memory impairment in schizophrenia?
A new concept for crisis management in borderline patients
Friess, E.
Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression
GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety
Fritzer, G.
A new model for assessment of mechanisms of behavior control and impulsivity
Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity
Modulation of sleep: A new approach of treating memory impairment in schizophrenia?
Frodl, T.
Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients
Differences in cortical activation by a working memory task after substitution of atypical neuroleptics
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study
Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics
Frommann, I.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Frye, M. A.
Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study
Fuchs, B.
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
Prediction of response to antidepressant monotherapy
Is there a genetic continuum between anxiety and depression?
Fuchsberger, T.
Neural representation of cognitive changes within the visual system in the AD brain
Gaebel, W.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Alcohol-craving: Therapeutic effects using fMRI
Gaertner, I.
TDM of psychoactive medication in the risk patient
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Gallhofer, B.
Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients
Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls
Subjective reactions to neuroleptic treatment: Prediction of compliance?
Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia
Gallinat, J.
EEG source localization during postictal delirium following electroconvulsive therapy
Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability
Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Galwas, C.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Gamma, A.
A longitudinal syndrome-oriented approach to phenotypic heterogeneity
Garziella, M.
New scales for measuremant of anxiety in a study with hydroxyzine for patients with generalized anxiety disorder (GAS)
Gastpar, M.
Gabapentin as a mood stabiliser in the treatment of alcoholism-SAD-comorbidity
Gattaz, W. F.
Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia
Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex
Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment
Phospholipase a2 activity in rat embryonic brain and in primary cultures of cortical neurons
Phospholipase A2 inhibition in the rat hippocampus disrupts short- and long-term memory processing
Gebhardt, S.
Genetic aspects of antipsychotic induced body weight change
Genius, J. J. K.
Association of cerebrovascular disease with inflammatory polymorphisms with special reference to cerebral microangiopathy
Gerlach, M.
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Gerok-Falke, K.
A new concept for crisis management in borderline patients
Gertz, H. J.
Pharmacotherapeutic options in vascular dementia
Gescher, D.
Megestrol attenuates hormonal response to CCK-4
Gesierich, T.
Effective connectivity and pharmacological modulation in schizophrenia
Geyer, M. A.
Deficient information processing and dysfunctional cognitions in unmedicated panic disorder patients
Giegling, I.
A functional SNP (V158M) in the COMT gene is associated with aggressive personality traits
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments
An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia
Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis
Systematic screen of serotonergic genes in suicidal behaviour
Association study of SNPs in G72 and DAAO in schizophrenia
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene
cDNA arrays analyses in an animal model for psychosis-related traits
Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia
Giesler, M.
Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression
Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results
Gilg, T.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Gilling, K.
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Gimpl, G.
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Gjedde, A.
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography
Glatz, D.
Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease
Göbel, C.
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*
Godemann, F.
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study
Göder, R.
Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity
Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease
Modulation of sleep: A new approach of treating memory impairment in schizophrenia?
Goedecken, B.
Megestrol attenuates hormonal response to CCK-4
Goldman, D.
Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing
Gonnermann, C.
An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia
Gouzoulis-Mayfrank, E.
Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies
Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users
Grauer, M. T.
Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls
Results of routine CSF analysis of 1000 psychiatric patients
Graz, C.
Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Grecksch, G.
Kindling alters rewarding effects of ethanol, morphine and cocaine
Greetfeld, M.
Analysis of stress-induced CRH, CRHR1, AVP and mineralocorticoid receptor (MR) mRNA expression in C57/Bl6 mice: Implications for HPA-system regulation
Grimm, C.
Genetic variants influencing retinal degeneration and neuroprotection in the eye
Grodd, W.
Pharmako-FMRT in Alzheimers dementia
Grohmann, R.
Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP
Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program
Groß, W.
Predicting successful job performance of schizophrenics after discharge from hospital
Gruesser, S. M.
Relapse and gender specific activation of the striatum in alcohol dependent patients
Gründer, G.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography
Therapeutic drug monitoring of ziprasidone
Grunewald, R. W.
Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea
Grunze, H.
EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis
Treatment of bipolar depression
Gruppe, H.
Subjective reactions to neuroleptic treatment: Prediction of compliance?
Guan, Z.
Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects
Haack, M.
Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study
Early prediction of changes in weight during six weeks of treatment with antidepressants
Haag, A.
Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results
Haass, C.
Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway
Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner
Habel, U.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Haberger, C.
A new diagnostic tool for measuring attentional components in patients with depression
Haberhausen, M.
Genetic aspects of antipsychotic induced body weight change
Habersetzer, U.
Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism
Habrat, B.
Alanine aminopeptidase (AAP) activity in urine: A new marker of chronic alcohol abuse?
Combination of nephro- and hepatotoxicity of alcohol to improve diagnostic performance of markers of alcohol abuse
Haen, E.
Benefit of modern antipsychotics still withheld from forensic patients
Perazine – the atypical side of an conventional antipsychotic
Psychopharmacotherapy and adverse drug effects in old age psychiatry
Gender effects in olanzapine metabolism
Changes in the effectiveness of drugs in elderly people
Hagemeyer, T. P.
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress
Hagen, T.
Hippocampal volume reduction and HPA-system activity in major depression
Hagenhoff, M.
Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients
Hahn, K.
Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics
Hahn, R.
Multimorbidity in the elderly in a geriatric hospital
Hajak, G.
Benefit of modern antipsychotics still withheld from forensic patients
Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment
Perazine – the atypical side of an conventional antipsychotic
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses
Cortical excitability in neuroleptic-naive first-episode schizophrenic patients
Cortical excitability in patients with adult ADHD
Gender effects in olanzapine metabolism
High-frequency transcranial magnetic stimulation in schizophrenia
High-frequency transcranial magnetic stimulation decreases cigarette smoking
Hamann, J.
Language Bias in Neuroscience – Is the Tower of Babel located in Germany?
Psychotropic polypharmacy. An analysis of a large outpatient prescription database
Hamark, L.
Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm
Hamke, M.
Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P
Hammel, S.
Psychopharmacological treatment from the patients’ perspective. A computer-based automatic interview system
Hampel, H.
Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry
Association of cerebrovascular disease with inflammatory polymorphisms with special reference to cerebral microangiopathy
Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease
A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia
Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Phosphorylated tau protein as a core biomarker of Alzheimer’s disease
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease
Neural representation of cognitive changes within the visual system in the AD brain
Hanewald, B.
Subjective reactions to neuroleptic treatment: Prediction of compliance?
Hanisch, M.
Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia
Hapfelmeier, G.
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
Hartmann, A. M.
Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease
Association study of SNPs in G72 and DAAO in schizophrenia
cDNA arrays analyses in an animal model for psychosis-related traits
Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia
Härtter, S.
P-glycoprotein (P-gp) affects the pharmacodynamics and of the atypical antipsychotic amisulpride
Therapeutic drug monitoring (TDM) of quetiapine
Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?
Costs and effectiveness of therapeutic drug monitoring in psychiatry
Therapeutic drug monitoring of ziprasidone
Haseneder, R.
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
Hatzinger, M.
Predictive value of sleep EEG markers in long-term course of depression
GABAergic modulation during PSD, effects on microsleep and NonREM-sleep in volunteers and patients with major depression
Hauke, W.
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*
Havemann-Reinecke, U.
Effects of therapy of attention deficit hyperactivity disorder (ADHD) in the childhood with α-methylphenidate (MPH) on addiction diseases and psychiatric comorbidity
Hebebrand, J.
Genetic aspects of antipsychotic induced body weight change
Hegerl, U.
EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI
Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*
Kinematic analysis of the effect of neuroleptics on facial expressions and hand writing in schizophrenic patients
Heimberg, E.
Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease
Heindl, B.
Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment
Heinz, A.
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography
Relapse and gender specific activation of the striatum in alcohol dependent patients
Heinzel-Gutenbrunner, M.
Genetic aspects of antipsychotic induced body weight change
Held, K.
Nocturnal ghrelin levels in normal controls – effects of gender
Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium
Ghrelin promotes slow-wave sleep in man
GHRH impairs sleep in normal females
Hellweg, R.
Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability
Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients
Hemmer, B.
Cytoimmunological changes and treatment response in major depression
Hemmeter, U.
Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression
Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results
Predictive value of sleep EEG markers in long-term course of depression
GABAergic modulation during PSD, effects on microsleep and NonREM-sleep in volunteers and patients with major depression
Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm
Henkel, V.
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Henn, F. A.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Hennig, J.
A new measure of the dopamine challenge by bromocriptine for testing personality
Influence of mirtazapine on salivary cortisol in depressed patients
Henniger, M. S. H.
Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants
Choosing the right black mice – a matter of particular importance!
Henning, U.
In vitro, inhibition of oxidative stress prevents clozapine-induced apoptosis in neutrophils
Proteomics reveals differential protein regulation in human glioma cells by imipramine
In vitro autoregulation of glucocorticoid receptors is dependent on the medium and serum batch used
Increased sensitivity of isolated CD34+ cells towards clozapine-treatment
Transport of clozapine and its major metabolites into human cells of glial and neuronal origin
Clozapine transport into human glioblastoma cells is increased after prolonged incubation with neuroleptic drugs
Metabolism of clozapine-N-oxid in disrupted cells of neuronal and blood cell origin
Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal
Heppekausen, K.
Is premature termination of opiate detoxification due to intensive withdrawal or craving?
Heres, S.
Language Bias in Neuroscience – Is the Tower of Babel located in Germany?
Hermann, D.
Relapse and gender specific activation of the striatum in alcohol dependent patients
Hermann, H.
The roles of the endogenous cannabinoid system in learning and memory in mice
Herpfer, I.
Modulation of neuropeptidergic circuits
Substance P and substance P antagonists in the pathology and treatment of affective disorders
Herr, A. S.
Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro
Herr, R.
Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital
Hesse, A.
The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram
Hesse, A. C.
Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease
Hetzel, G.
High basal prolactin values predict response to reboxetine treatment in major depression
The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
Visually-evoked event-related potentials and oral citalopram challenge test
Heuser, I.
Dexamethasone suppression test (DST): Simultaneous Investigation of confounding variables predicting Individual extend of suppression in depression – A multiple regression analysis
Serum and cerebrospinal fluid concentration of Substance P before and after treatment of depressed patients
The effect of mirtazapine on cerebrovascular reactivity – A randomized, double-blind placebo-controlled study in healthy volunteers
Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?
Altered cortical inhibition after electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)
The significance of non-REM sleep for memory processes in elderly subjects
Hippocampal volume reduction and HPA-system activity in major depression
Hiemke, C.
P-glycoprotein (P-gp) affects the pharmacodynamics and of the atypical antipsychotic amisulpride
Therapeutic drug monitoring (TDM) of quetiapine
Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?
Therapeutic drug monitoring (TDM) of donepezil
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Costs and effectiveness of therapeutic drug monitoring in psychiatry
Therapeutic drug monitoring of ziprasidone
Hillemacher, T.
Craving differs with alcoholic beverages
Himmerich, H.
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study
Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain
Early prediction of changes in weight during six weeks of treatment with antidepressants
Body weight and the plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium
Epidemiology and mechanisms of weight gain induced by psychotropic drugs
Hinze-Selch, D.
Changes in CREB-phosphorylation during recovery from major depression: Findings in patients exclusively treated with psychotherapy (IPT)
A psychoeducative-cognitive group setting for patients with schizophrenia: Making use of newly gained neuroplasticity
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study
Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity
Modulation of sleep: A new approach of treating memory impairment in schizophrenia?
Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings
Effect of antipsychotics on microglia in vitro
Neurotrophic factors and the regulation of CREB as a marker and putative predictor of treatment response in major depression
Hirsch, J.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Hobusch, K.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Hoefgen, B.
CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?
Hofer, A.
Alterations of glucose metabolism under treatment with atypical antipsychotics
Höger, C.
Effects of therapy of attention deficit hyperactivity disorder (ADHD) in the childhood with α-methylphenidate (MPH) on addiction diseases and psychiatric comorbidity
Höhne, T.
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Höllt, V.
The mu opioid receptor: Molecular and functional aspects
Holsboer, F.
Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla
The co-chaperone BAG-1 as a candidate for causing cortisteroid receptor resistance: A detailed mutational analysis
Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides
Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone
Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study
Neuropsychological deficits and long-term outcomes in patients with affective disorders
Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro
The effects of RS-86 on sleep with respect to depression and HLA-type
The youth hormone DHEA: A benefit for pathologic sleep alterations?
GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety
Role of chaperones in signal transduction of the glucocorticoid receptor
A functional genetic screen to identify factors involved in glucocorticoid receptor (GR) transactivation
Analysis of cerebrospinal fluid of depressed patients
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study
Prediction of response to antidepressant monotherapy
Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders
Is there a genetic continuum between anxiety and depression?
Holsboer-Trachsler, E.
Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression
Predictive value of sleep EEG markers in long-term course of depression
GABAergic modulation during PSD, effects on microsleep and NonREM-sleep in volunteers and patients with major depression
Ginkgo biloba in the treatment of antidepressant-induced sexual dysfunction: The results of the Swiss exploratory study in depressed patients
Holzner, B.
Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?
Hornung, O. P.
Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?
The significance of non-REM sleep for memory processes in elderly subjects
Horrobin, D.
Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression
Huber, J.
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
Huber, M. T.
Computational biology of sensitization: Pharmacologically- relevant amplification mechanisms
Huber, P.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Leptin levels of alcohol abstainers and detoxification patients are not different
Huchzermeier, C.
Changes in CREB-phosphorylation during recovery from major depression: Findings in patients exclusively treated with psychotherapy (IPT)
Neurotrophic factors and the regulation of CREB as a marker and putative predictor of treatment response in major depression
Huebner-Liebermann, B.
Antidepressants from an internet-patients’ viewpoint
Hüll, M.
Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells
Hummer, M.
Alterations of glucose metabolism under treatment with atypical antipsychotics
Hunsche, S.
Effective connectivity and pharmacological modulation in schizophrenia
Ibach, B.
Psychopharmacotherapy and adverse drug effects in old age psychiatry
Impler, E. M.
Association study of SNPs in G72 and DAAO in schizophrenia
Ising, M.
Nocturnal ghrelin levels in normal controls – effects of gender
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Ghrelin promotes slow-wave sleep in man
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
The effects of RS-86 on sleep with respect to depression and HLA-type
Evaluation of 1H-MRS as diagnostic marker for mild cognitive impairment and dementia
Prediction of response to antidepressant monotherapy
Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects
Is there a genetic continuum between anxiety and depression?
Jachau, K.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Jacob, A.
Analysis of cerebrospinal fluid of depressed patients
Jacob, W.
Validation of a genetic mouse model for anxiety and comorbid depression
Jacobi, F.
High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression
Jäger, L.
Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI
Jäger, M.
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Jahn, H.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Gender effects in pharmacological relapse prevention of alcoholism
Megestrol attenuates hormonal response to CCK-4
Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide
Gender effects in depression: Influence of HPA axis activity and steroid synthesis inhibitors
Jahn, T.
D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate
Jakob, F.
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Janssen, B.
How do psychiatrists and schizophrenic patients assess treatment and outcome in outpatient care?
Subjective quality of life and treatment strategies in schizophrenia outpatient care
Cost effectiveness of different treatment strategies in schizophrenia outpatient care
Jaquenoud-Sirot, E.
Interactions between somatic and psychotropic drugs: pharmacokinetic and pharmacodynamic consequences.
Jockers-Scherübl, M. C.
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study
Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients
Johann, M.
High-frequency transcranial magnetic stimulation decreases cigarette smoking
Jordan, W.
Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects
Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy
Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea
Juckel, G.
EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI
Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*
Kinematic analysis of the effect of neuroleptics on facial expressions and hand writing in schizophrenic patients
Kalisch, R.
Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla
Kamprath, K.
The roles of the endogenous cannabinoid system in learning and memory in mice
Kapfhammer, H. P.
Treatment of depression with antidepressant medications in patients with cardiovascular disease
Karow, A.
Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study
Kastrup, A.
Treatment of tics in Tourette’s syndrome with aripiprazole
Kaufmann, B.
Effective connectivity and pharmacological modulation in schizophrenia
Kaufmann, C.
Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study
Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study
Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain
Early prediction of changes in weight during six weeks of treatment with antidepressants
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study
Keck, M. E.
ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders
Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis
Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal
Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism
Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders
Is there a genetic continuum between anxiety and depression?
Keil, U.
Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway
Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner
Kell, S.
Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings
Effect of antipsychotics on microglia in vitro
Kellermann, T.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Kellner, M.
Megestrol attenuates hormonal response to CCK-4
Kemmler, G.
Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?
Alterations of glucose metabolism under treatment with atypical antipsychotics
Kerchlango, A.
Psychopharmacotherapy and adverse drug effects in old age psychiatry
Kern, N.
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
Prediction of response to antidepressant monotherapy
Is there a genetic continuum between anxiety and depression?
Keßler, M.
Validation of a genetic mouse model for anxiety and comorbid depression
Kiefer, F.
Gender effects in pharmacological relapse prevention of alcoholism
The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study
Kießlinger, U.
Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression
Kircher, T.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Pharmako-FMRT in Alzheimers dementia
Kirchheiner, J.
Pharmacogenetics based therapeutic recommendations in antidepressant drug therapy
Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression
Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients
Kirchner, H.
Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B
Kirner, A.
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments
Long term electroconvulsive treatment as maintenance and prophylactic therapy of affective disorders
Kirschbaum, C.
Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal
Kissling, W.
How do psychiatrists and schizophrenic patients assess treatment and outcome in outpatient care?
Subjective quality of life and treatment strategies in schizophrenia outpatient care
Cost effectiveness of different treatment strategies in schizophrenia outpatient care
Peer-to-peer education in schizophrenia: Impact for knowledge, compliance with neuroleptic relapse prevention and quality of life
Results of a pilot study about the effects of a new, video based psychoeducational program for neuroleptic relapse prevention
Language Bias in Neuroscience – Is the Tower of Babel located in Germany?
Psychotropic polypharmacy. An analysis of a large outpatient prescription database
Klein, H. E.
Benefit of modern antipsychotics still withheld from forensic patients
The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression
Subjective response to psychotropic drugs in psychiatric in-patients
Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment
Perazine – the atypical side of an conventional antipsychotic
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses
Psychopharmacotherapy and adverse drug effects in old age psychiatry
Antidepressants from an internet-patients’ viewpoint
Klein, M.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Klein, S.
Relapse and gender specific activation of the striatum in alcohol dependent patients
Kleinlogel, H.
Pharmaco-EEG-monitoring predicts antipsychotic efficacy of atypical antipsychotic drugs
Klieser, E.
Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders?
Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study
Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone
Effectiveness of music therapy on pain reduction and psychopharmacotherapy
Klimke, A.
In vitro, inhibition of oxidative stress prevents clozapine-induced apoptosis in neutrophils
Proteomics reveals differential protein regulation in human glioma cells by imipramine
In vitro autoregulation of glucocorticoid receptors is dependent on the medium and serum batch used
Increased sensitivity of isolated CD34+ cells towards clozapine-treatment
Transport of clozapine and its major metabolites into human cells of glial and neuronal origin
Clozapine transport into human glioblastoma cells is increased after prolonged incubation with neuroleptic drugs
Metabolism of clozapine-N-oxid in disrupted cells of neuronal and blood cell origin
Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal
Knolle-Veentjer, S.
A psychoeducative-cognitive group setting for patients with schizophrenia: Making use of newly gained neuroplasticity
Koch, J. M.
Changes in CREB-phosphorylation during recovery from major depression: Findings in patients exclusively treated with psychotherapy (IPT)
Antidepressants increase CREB-phosphorylation via the 5-HT(1A)-receptor
Neurotrophic factors and the regulation of CREB as a marker and putative predictor of treatment response in major depression
Koch, W.
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Koerner, C.
Reversible pitch perception shift caused by trimipramine
Koethe, D.
Body weight and the plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium
Kohl, C.
Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?
Köhnlein, O.
Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany
Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital
Kopf, D.
Lipid metabolism and insulin resistance in depressed patients: Significance of weight, hypercortisolemia and antidepressant treatment
Kopitz, J.
Therapeutic drug monitoring data: No influence of amisulpride on clozapine plasma concentration
Kornhuber, J.
CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Neurochemical early and differential diagnosis of Alzheimer’s dementia
Craving differs with alcoholic beverages
Kostorz, L.
Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal
Kotter, G.
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Kraft, E.
Differences in cortical activation by a working memory task after substitution of atypical neuroleptics
Krampe, H.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Kraus, T.
Leptin plasma levels and craving data during alcohol withdrawal
Epidemiology and mechanisms of weight gain induced by psychotropic drugs
Krausz, M.
Antipsychotic treatment in schizophrenic patients. 6-month data of the 3-year European observational study of health outcomes (SOHO)
Krell, D.
The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study
Kress, K. R.
Therapeutic drug monitoring data: No influence of amisulpride on clozapine plasma concentration
Krieg, J. C.
Cytoimmunological changes and treatment response in major depression
Cytokines, the regulation of body weight and psychopharmacological treatment
Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression
Genetic aspects of antipsychotic induced body weight change
Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results
Computational biology of sensitization: Pharmacologically- relevant amplification mechanisms
Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm
Krieger, K.
In vitro, inhibition of oxidative stress prevents clozapine-induced apoptosis in neutrophils
Proteomics reveals differential protein regulation in human glioma cells by imipramine
In vitro autoregulation of glucocorticoid receptors is dependent on the medium and serum batch used
Increased sensitivity of isolated CD34+ cells towards clozapine-treatment
Transport of clozapine and its major metabolites into human cells of glial and neuronal origin
Clozapine transport into human glioblastoma cells is increased after prolonged incubation with neuroleptic drugs
Metabolism of clozapine-N-oxid in disrupted cells of neuronal and blood cell origin
Krieger, S.
Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients
Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls
Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia
Krömer, S. A.
Validation of a genetic mouse model for anxiety and comorbid depression
Kromolan, B.
Craving differs with alcoholic beverages
Kronenberg, G.
Hippocampal volume reduction and HPA-system activity in major depression
Kronenwett, R.
Increased sensitivity of isolated CD34+ cells towards clozapine-treatment
Kröner-Herwig, B.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Kropp, S.
Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP
Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration
Kuenzel, H. E.
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Kuhn, H. G.
Adult neurogenesis
Kuhn, K.
Dose related frequency of EPMS in patients treated with flupentixol decanoate versus risperidone
Kühn, K. U.
Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride
Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls
Kungel, M.
Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia
Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia
Efficacy of aripiprazole in the treatment of mania
Künzel, H. E.
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
Prediction of response to antidepressant monotherapy
Is there a genetic continuum between anxiety and depression?
Kuss, H. J.
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Laakmann, G.
Influence of mirtazapine on salivary cortisol in depressed patients
LaFougere, G.
Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics
Lammers, C. H.
Clonidine for hypernoradrenergic symptoms In patients with borderline personality disorder
Lancel, M.
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study
The youth hormone DHEA: A benefit for pathologic sleep alterations?
GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety
Landgraf, R.
Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP
Validation of a genetic mouse model for anxiety and comorbid depression
Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders
Lang, U. E.
Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability
Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients
Lange, K. W.
The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression
Lange-Asschenfeld, C.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Langguth, B.
Cortical excitability in neuroleptic-naive first-episode schizophrenic patients
Cortical excitability in patients with adult ADHD
High-frequency transcranial magnetic stimulation in schizophrenia
High-frequency transcranial magnetic stimulation decreases cigarette smoking
Lanquillon, S.
Benefit of modern antipsychotics still withheld from forensic patients
Perazine – the atypical side of an conventional antipsychotic
Lauer, C.
The effects of RS-86 on sleep with respect to depression and HLA-type
Laufkötter, R.
Cortical excitability in patients with adult ADHD
Laux, G.
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Lechleitner, M.
Alterations of glucose metabolism under treatment with atypical antipsychotics
Lederbogen, F.
Circadian blood pressure regulation in hospitalized depressed patients and non-depressed comparison subjects
Lehmann, A.
Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis
Lehner, M.
Alanine aminopeptidase (AAP) activity in urine: A new marker of chronic alcohol abuse?
Combination of nephro- and hepatotoxicity of alcohol to improve diagnostic performance of markers of alcohol abuse
Leicht, G.
Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI
Leinsinger, G.
Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Neural representation of cognitive changes within the visual system in the AD brain
Lemke, M. R.
A new model for assessment of mechanisms of behavior control and impulsivity
Lemmer, W.
Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders?
Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study
Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone
Effectiveness of music therapy on pain reduction and psychopharmacotherapy
Lenoci, M.
Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder
Lenzen, K.
From mouse models to human behavior: Testing candidate genes for alcoholism
Leube, D.
Pharmako-FMRT in Alzheimers dementia
Leucht, S.
Language Bias in Neuroscience – Is the Tower of Babel located in Germany?
Lewczuk, P.
Neurochemical early and differential diagnosis of Alzheimer’s dementia
Lewitzka, U.
Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects
Lichtner, P.
Evidence for genetic heterogeneity in Restless Legs Syndrome
Lichy, C.
Association of cerebrovascular disease with inflammatory polymorphisms with special reference to cerebral microangiopathy
Lieb, K.
Modulation of neuropeptidergic circuits
Substance P and substance P antagonists in the pathology and treatment of affective disorders
Serum and cerebrospinal fluid concentration of Substance P before and after treatment of depressed patients
Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells
Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P
Clonidine in the treatment of acute states of aversive tension and dissociation in female patients with borderline personality disorder
Linka, T.
The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram
Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program
Lis, S.
Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls
Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia
Lochmann, M.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Loeffler, S.
In vitro, inhibition of oxidative stress prevents clozapine-induced apoptosis in neutrophils
Increased sensitivity of isolated CD34+ cells towards clozapine-treatment
Transport of clozapine and its major metabolites into human cells of glial and neuronal origin
Lojewski, I.
Effects of therapy of attention deficit hyperactivity disorder (ADHD) in the childhood with α-methylphenidate (MPH) on addiction diseases and psychiatric comorbidity
London, E. D.
Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study
Lopez-Bayo, P.
Neural representation of cognitive changes within the visual system in the AD brain
Lorberg, C.
Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients
Lucae, S.
Is there a genetic continuum between anxiety and depression?
Ludewig, K.
Different aspects of executive function in first episode schizophrenia
Deficient information processing and dysfunctional cognitions in unmedicated panic disorder patients
Ludewig, S.
Different aspects of executive function in first episode schizophrenia
Deficient information processing and dysfunctional cognitions in unmedicated panic disorder patients
Lujic, C.
A new measure of the dopamine challenge by bromocriptine for testing personality
Lunkenheimer, J.
CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Lutz, B.
The roles of the endogenous cannabinoid system in learning and memory in mice
Lutz, R.
Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany
Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital
Maccarrone, G.
Analysis of cerebrospinal fluid of depressed patients
Mager, T.
D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate
Mahlberg, R.
Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients
Mahlke, K.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Maier, W.
Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride
Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls
CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?
Pharmacogenetic methods for rational drug choice
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence
Majer, M.
Neuropsychological deficits and long-term outcomes in patients with affective disorders
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
Prediction of response to antidepressant monotherapy
Maler, M.
Neurochemical early and differential diagnosis of Alzheimer’s dementia
Mann, K.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Relapse and gender specific activation of the striatum in alcohol dependent patients
Marcus, R.
Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia
Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia
Efficacy of aripiprazole in the treatment of mania
Marmar, C. R.
Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder
Marocco, J.
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Marques, C. A.
Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway
Marsicano, G.
The roles of the endogenous cannabinoid system in learning and memory in mice
Martin, M.
Genetic aspects of antipsychotic induced body weight change
Martin, P.
Different aspects of executive function in first episode schizophrenia
Mass, R.
The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study
Mathias, S.
Nocturnal ghrelin levels in normal controls – effects of gender
Ghrelin promotes slow-wave sleep in man
Modulation of GABAergic systems with GABA agonists and antagonists, effects on sleep EEG and hormone secretion
GHRH impairs sleep in normal females
Matthies, U.
Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients
Maurer, C.
Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital
Mavrogiorgou, P.
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*
Mayer, G.
Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy
Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea
Mazziotta, J. C.
Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study
Meichel, K.
Hippocampal volume reduction and HPA-system activity in major depression
Meier, A.
Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects
Meisenzahl, E. M.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients
Differences in cortical activation by a working memory task after substitution of atypical neuroleptics
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study
Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics
Meitinger, T.
Evidence for genetic heterogeneity in Restless Legs Syndrome
Mendes, C. T.
Phospholipase a2 activity in rat embryonic brain and in primary cultures of cortical neurons
Meraner, V.
Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?
Mergl, R.
EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*
Kinematic analysis of the effect of neuroleptics on facial expressions and hand writing in schizophrenic patients
Messer, T.
Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany
Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital
Metten, M.
CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?
Metzler, T. J.
Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder
Meyer-Lindenberg, A.
Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls
Michael, N.
High basal prolactin values predict response to reboxetine treatment in major depression
The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
Visually-evoked event-related potentials and oral citalopram challenge test
Michel, K.
New insights into the role of the opioid system as mediator of drug addiction by studies in transgenic mice
Michelson, D.
Efficacy and safety of atomoxetine in adults with attention deficit/hyperactivity disorder
Pharmacologic properties of atomoxetine: a novel treatment for attention deficit/hyperactivity disorder
Milfay, D.
Validation of a genetic mouse model for anxiety and comorbid depression
Minov, C.
Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany
Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital
Mirowska, D.
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone
Missler, U.
Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B
Mobascher, A.
Clozapine transport into human glioblastoma cells is increased after prolonged incubation with neuroleptic drugs
Modell, S.
Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia
Efficacy of aripiprazole in the treatment of mania
Neuropsychological deficits and long-term outcomes in patients with affective disorders
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
The effects of RS-86 on sleep with respect to depression and HLA-type
Prediction of response to antidepressant monotherapy
Is there a genetic continuum between anxiety and depression?
Moeller, O.
High basal prolactin values predict response to reboxetine treatment in major depression
The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
Visually-evoked event-related potentials and oral citalopram challenge test
Moller, H. J.
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene
Möller, H. J.
Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients
A functional SNP (V158M) in the COMT gene is associated with aggressive personality traits
Differences in cortical activation by a working memory task after substitution of atypical neuroleptics
Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study
Different protein expression levels after antidepressant treatment on EBV cells of depressed patients
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease
Systematic screen of serotonergic genes in suicidal behaviour
A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics
Association study of SNPs in G72 and DAAO in schizophrenia
Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease
Neural representation of cognitive changes within the visual system in the AD brain
Möller-Hartmann, W.
Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies
Monory, K.
The roles of the endogenous cannabinoid system in learning and memory in mice
Morgenthaler, N.
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease
Mossiaguine, I.
The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis
IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis
Mössner, R.
An organic cation transporter capable of transporting serotonin is upregulated in serotonin transporter-deficient mice
Mueller-Oerlinghausen, B.
IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis
Mulert, C.
EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI
Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity
Müller, B. W.
The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram
Müller, J.
An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia
Müller, J. L.
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses
Müller, K. M.
Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital
Müller, M. B.
Analysis of stress-induced CRH, CRHR1, AVP and mineralocorticoid receptor (MR) mRNA expression in C57/Bl6 mice: Implications for HPA-system regulation
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress
Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders
Müller, M. J.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Therapeutic drug monitoring (TDM) of quetiapine
Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital
Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?
The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects
Müller, W. E.
Hyperforin activates nonselective cation channels – A new mechanism of antidepressant activity
Activation of nonselective cation channels by hyperforin – A novel mechanism of antidepressant activity
Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway
Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner
Müller-Myhsok, B.
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Evidence for genetic heterogeneity in Restless Legs Syndrome
Is there a genetic continuum between anxiety and depression?
Müller-Oerlinghausen, B.
The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects
Müller-Siecheneder, F.
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Long term electroconvulsive treatment as maintenance and prophylactic therapy of affective disorders
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Müller-Spahn, F.
Cognitive performance, behavioural and psychological symptoms, and circadian rhythm disturbances in Alzheimer’s disease patients treated with quetiapine or haloperidol
Murck, H.
Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression
Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium
Magnesium-deficient diet alters depression and anxiety-related behavior in mice – Influence of desipramine and hypericum extract
Gender differences in sleep endocrine regulation following administration of growth-hormone releasing hormone (GHRH) – relevance for the pathophysiology of major depression
Murgatroyd, C.
Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP
Naber, D.
Antipsychotic treatment in schizophrenic patients. 6-month data of the 3-year European observational study of health outcomes (SOHO)
The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study
Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study
Namendorf, C.
Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls
Netter, P.
A new measure of the dopamine challenge by bromocriptine for testing personality
Neu, P.
The effect of mirtazapine on cerebrovascular reactivity – A randomized, double-blind placebo-controlled study in healthy volunteers
Neuhaus, A.
Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis
Neuhaus, A. H.
EEG source localization during postictal delirium following electroconvulsive therapy
Altered cortical inhibition after electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)
Neumeier, K.
Different protein expression levels after antidepressant treatment on EBV cells of depressed patients
Neylan, T. C.
Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder
Nickel, T.
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
Prediction of response to antidepressant monotherapy
Niedmann, P.
Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy
Nietmann, P. D.
Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration
Nissen, C.
Transient narcolepsy-cataplexy-syndrome after discontinuation of the antidepressant venlafaxine
Normann, C.
Modulation of Ca2+ currents and long-term synaptic plasticity by SSRIs
Norra, C.
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Novick, D.
Antipsychotic treatment in schizophrenic patients. 6-month data of the 3-year European observational study of health outcomes (SOHO)
Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study
Nuernberger, P.
From mouse models to human behavior: Testing candidate genes for alcoholism
Nunes, P. V.
Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex
Nyhuis, P. W.
Gabapentin as a mood stabiliser in the treatment of alcoholism-SAD-comorbidity
Oehl, M. A.
Alterations of glucose metabolism under treatment with atypical antipsychotics
Ogel, N.
The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects
Ohl, F.
ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders
Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides
Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants
Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis
Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism
Refinement of inbred mouse strains as animal models for psychiatric disorders
Influence of circadian factors on behavioral and cognitive testing in mice
Ometto, M.
Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia
Opgen-Rhein, C.
Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome
Ostermeier, C. P.
Subjective response to psychotropic drugs in psychiatric in-patients
Otte, C.
Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder
Ottomeyer, C.
Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells
Padberg, F.
EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Panhuysen, M.
Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants
Parsons, C.
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Pechler, S.
Neural representation of cognitive changes within the visual system in the AD brain
Pedrosa Gil, F.
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression
Penzel, T.
Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm
Perfahl, M.
Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses
Peters, M.
Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B
Petersen, I.
Effect of antipsychotics on microglia in vitro
Pfeiff, L.
Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses
Pfennig, A.
HPA axis dysregulation and suicidal behavior in depression – Differentiation of a genetically distinct subgroup?
Munich Vulnerability Study – Familial vulnerability for affective disorders: Search for endophenotypes
Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders
Prediction of response to antidepressant monotherapy
Is there a genetic continuum between anxiety and depression?
Pfister, H.
High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression
Philipsen, X.
Clonidine in the treatment of acute states of aversive tension and dissociation in female patients with borderline personality disorder
Pich, M.
Interferon-alpha treatment and serotonergic dysfunction
Pitschel-Walz, G.
Peer-to-peer education in schizophrenia: Impact for knowledge, compliance with neuroleptic relapse prevention and quality of life
Results of a pilot study about the effects of a new, video based psychoeducational program for neuroleptic relapse prevention
Plewnia, C.
Treatment of tics in Tourette’s syndrome with aripiprazole
Plodeck, V.
CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Pogarell, O.
EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Effects of citalopram and reboxetine on the loudness dependence of auditory evoked potentials in patients with major depression
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI
Prediction of treatment response in major depression: The relationship between the serotonin-related LDAEP and the unspecific prediction related to anterior cingulate cortex activity
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*
Pohlmann, K.
Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects
Pollmächer, T.
Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study
Influence of sleep deprivation on plasma ghrelin levels in healthy subjects
Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study
Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study
Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain
Early prediction of changes in weight during six weeks of treatment with antidepressants
Body weight and the plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium
Epidemiology and mechanisms of weight gain induced by psychotropic drugs
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study
Ponath, G.
Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B
Pöpperl, G.
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Poser, W.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Poustka, F.
The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects
Pragst, F.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Preuss, U. W.
Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study
Pridzun, L.
Leptin levels of alcohol abstainers and detoxification patients are not different
Priebe, M.
Alcohol-craving: Therapeutic effects using fMRI
Propp, S.
Loudness dependency of the primary auditory cortex as an indicator of central serotonergic transmission: Combination of EEG and fMRI
Pruessner, J. C.
Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Pugner, K.
Psychotropic polypharmacy. An analysis of a large outpatient prescription database
Putzhammer, A.
The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression
Ultrasonic gait analysis: Differentiation of effects of schizophrenia and of antipsychotic treatment
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses
Quednow, B. B.
Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride
Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls
Racz, I.
New insights into the role of the opioid system as mediator of drug addiction by studies in transgenic mice
Räder, H.
Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis
Raedler, T.
Gender effects in pharmacological relapse prevention of alcoholism
Megestrol attenuates hormonal response to CCK-4
Sex-specific differences in pain-induced facial muscle activation
Rammes, G.
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Rao, M. L.
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Rapoport, S. I.
Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry
Rapp, A.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Rasgon, N.
Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study
Rau, T.
CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants
Reckemeyer, I.
Cytoimmunological changes and treatment response in major depression
Regen, F.
Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?
The significance of non-REM sleep for memory processes in elderly subjects
Regenbogen, B.
Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?
Reiff, J.
Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease
Rein, T.
The co-chaperone BAG-1 as a candidate for causing cortisteroid receptor resistance: A detailed mutational analysis
FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain
Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro
Role of chaperones in signal transduction of the glucocorticoid receptor
A functional genetic screen to identify factors involved in glucocorticoid receptor (GR) transactivation
Reinbacher, A.
Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea
Reinhold, J.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Reischies, F. M.
EEG source localization during postictal delirium following electroconvulsive therapy
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study
Reischle, E.
Perazine – the atypical side of an conventional antipsychotic
Reiser, M.
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Remé, C. E.
Genetic variants influencing retinal degeneration and neuroprotection in the eye
Remschmidt, H.
Genetic aspects of antipsychotic induced body weight change
Renders, L.
Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease
Reul, J. H. M. H.
Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress
Reulbach, U.
Leptin plasma levels and craving data during alcohol withdrawal
Reuter, M.
A new measure of the dopamine challenge by bromocriptine for testing personality
Rex, A.
Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats
Richter, A.
Predicting successful job performance of schizophrenics after discharge from hospital
Rickel, S.
Results of routine CSF analysis of 1000 psychiatric patients
Riederer, P.
Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Riemann, D.
Transient narcolepsy-cataplexy-syndrome after discontinuation of the antidepressant venlafaxine
Rippel, A.
Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls
Rist, F.
Is premature termination of opiate detoxification due to intensive withdrawal or craving?
Ritzhaupt, A.
Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study
Rocamora, R.
Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results
Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm
Rödel, A.
ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders
Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism
Influence of circadian factors on behavioral and cognitive testing in mice
Rodenbeck, A.
Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects
Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy
Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea
Roesch, F.
Association of clinical and non-clinical factors with subjective well-being – data of the SOHO study
Röhling, K.
A new concept for crisis management in borderline patients
Romeo, E.
GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety
Roots, I.
The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis
Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients
Röpke, S.
Dexamethasone suppression test (DST): Simultaneous Investigation of confounding variables predicting Individual extend of suppression in depression – A multiple regression analysis
Altered cortical inhibition after electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)
Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis
Rosenhagen, M.
The co-chaperone BAG-1 as a candidate for causing cortisteroid receptor resistance: A detailed mutational analysis
Role of chaperones in signal transduction of the glucocorticoid receptor
Analysis of cerebrospinal fluid of depressed patients
Rössler, W.
A longitudinal syndrome-oriented approach to phenotypic heterogeneity
Rothenberger, A.
Effects of therapy of attention deficit hyperactivity disorder (ADHD) in the childhood with α-methylphenidate (MPH) on addiction diseases and psychiatric comorbidity
Rothenhäusler, H. B.
Treatment of depression with antidepressant medications in patients with cardiovascular disease
Rothermundt, M.
The impact of reboxetine and citalopram on visually-evoked event-related potentials in depressed patients
Visually-evoked event-related potentials and oral citalopram challenge test
Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B
Rudolf, S.
Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B
Rüegg, J.
A functional genetic screen to identify factors involved in glucocorticoid receptor (GR) transactivation
Rufer, D.
Saccadic eye movements and cognitive performance in schizophrenic patients treated with clozapine or flupentixol
Ruhrmann, S.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Rujescu, D.
A functional SNP (V158M) in the COMT gene is associated with aggressive personality traits
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments
An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia
Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis
Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease
Systematic screen of serotonergic genes in suicidal behaviour
Association study of SNPs in G72 and DAAO in schizophrenia
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene
cDNA arrays analyses in an animal model for psychosis-related traits
Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia
Rummel, C.
Peer-to-peer education in schizophrenia: Impact for knowledge, compliance with neuroleptic relapse prevention and quality of life
Results of a pilot study about the effects of a new, video based psychoeducational program for neuroleptic relapse prevention
Ruppert, A.
Psychotropic polypharmacy. An analysis of a large outpatient prescription database
Rupprecht, R.
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Gender influence on pharmacogenetic prediction of antidepressive efficacy
Modulation of ligand-gated ion channels by antidepressants
GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
Rüther, E.
Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration
Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects
Serum homocysteine in obstructive sleep apnea syndrome can be lowered by CPAP-therapy
Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program
Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea
Sachse, C.
Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients
Sachse, J.
Therapeutic drug monitoring (TDM) of quetiapine
Naturalistic treatment of positive symptoms in schizophrenia with amisulpride: Are there gender differences?
Therapeutic drug monitoring (TDM) of donepezil
Costs and effectiveness of therapeutic drug monitoring in psychiatry
Therapeutic drug monitoring of ziprasidone
Samadi, P.
Effect of antipsychotics on microglia in vitro
Sand, P.
Gender effects in olanzapine metabolism
Sander, T.
Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome
Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing
From mouse models to human behavior: Testing candidate genes for alcoholism
Sartor, H.
The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression
Sartory, G.
The intensity dependence of the auditory evoked N1/P2-ERP-component increases in pharmacotherapy of major depression with citalopram
Sasse, J.
Frequency of Cyp2D6, 2C9, 2C19 polymorphisms in depressive and schizophrenic patients
Sauer, H.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Savaskan, E.
Cognitive performance, behavioural and psychological symptoms, and circadian rhythm disturbances in Alzheimer’s disease patients treated with quetiapine or haloperidol
Schaefer, M.
Interferon-alpha treatment and serotonergic dysfunction
Schaeffer, E. L.
Phospholipase a2 activity in rat embryonic brain and in primary cultures of cortical neurons
Phospholipase A2 inhibition in the rat hippocampus disrupts short- and long-term memory processing
Schafer, M.
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene
Schapiro, M. B.
Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry
Schaub, R.
IgG- Fcγ- receptor polymorphisms in drug-induced-induced agranulocytosis
Scherb, C.
Effective connectivity and pharmacological modulation in schizophrenia
Scherbaum, N.
Is premature termination of opiate detoxification due to intensive withdrawal or craving?
Scherer, J.
D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate
Dose related frequency of EPMS in patients treated with flupentixol decanoate versus risperidone
Scheurich, A.
The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects
Schewe, H. J.
Saccadic eye movements and cognitive performance in schizophrenic patients treated with clozapine or flupentixol
Schick, M.
Gender effects in depression: Influence of HPA axis activity and steroid synthesis inhibitors
Schickert, R.
Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats
Schiffelholz, T.
Novel object presentation affects sleep-wake behavior in rats
Perinatal, subchronic NMDA receptor antagonism attenuates behavior from childhood to adulthood in rats
The youth hormone DHEA: A benefit for pathologic sleep alterations?
Schild, H.
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence
Schildberg, F.
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence
Schillen, T.
Electronic monitoring of the cortisol daytime profiles during the process of alcohol withdrawal
Schindehütte, J.
Restaurative therapy for Parkinson’s disease
Schindler, F.
The NSAID rofecoxib reduces subjective cognitive impairment associated with ECT
Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis
Schlattmann, P.
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study
Schlösser, R.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Effective connectivity and pharmacological modulation in schizophrenia
Schlotter, W.
Treatment of tics in Tourette’s syndrome with aripiprazole
Schmaus, W.
Dose related frequency of EPMS in patients treated with flupentixol decanoate versus risperidone
Schmauß, M.
Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany
Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital
Schmid, D. A.
Nocturnal ghrelin levels in normal controls – effects of gender
Ghrelin promotes slow-wave sleep in man
Schmid, R.
Rhabdomyolysis associated with olanzapine monotherapy – A case report
Schmidt, L. G.
Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP
From mouse models to human behavior: Testing candidate genes for alcoholism
Attitudes towards different drug formulations in patients and staff members of a psychiatric hospital
Therapeutic drug monitoring (TDM) of donepezil
The specificity of weak central coherence: The neuropsychological profile of autistic patients in contrast to depressive patients, schizophrenic patients and control subjects
Schmidt, U.
The co-chaperone BAG-1 as a candidate for causing cortisteroid receptor resistance: A detailed mutational analysis
FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain
Role of chaperones in signal transduction of the glucocorticoid receptor
Schmidt, W.
Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal
Schmitt, A.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
An organic cation transporter capable of transporting serotonin is upregulated in serotonin transporter-deficient mice
Schmitt, G. J. E.
Striatal dopaminergic synapses In drug-naive versus haloperidol-treated schizophrenic patients
Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics
Schmitt, U.
P-glycoprotein (P-gp) affects the pharmacodynamics and of the atypical antipsychotic amisulpride
Schmitz, M.
Kindling alters rewarding effects of ethanol, morphine and cocaine
Schneider, F.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Alcohol-craving: Therapeutic effects using fMRI
Schneider, W.
A new diagnostic tool for measuring attentional components in patients with depression
Schnitker, R.
Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users
Schöchlin, C.
The repeatable battery for the assessment of neuropsychological status (BRANS) – A useful tool in neuropsychiatry?
Scholer, A.
Leptin levels of alcohol abstainers and detoxification patients are not different
Schommer, N. C.
Dexamethasone suppression test (DST): Simultaneous Investigation of confounding variables predicting Individual extend of suppression in depression – A multiple regression analysis
Schorr, C.
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Schreckenberger, M.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Schredl, M.
Does REM-sleep manipulation have a differential effect on learning and memory in healthy older adults?
Schreiber, W.
Predicting successful job performance of schizophrenics after discharge from hospital
Schreiber, Y. A.
Evaluation of 1H-MRS as diagnostic marker for mild cognitive impairment and dementia
Schreqdl, M.
The significance of non-REM sleep for memory processes in elderly subjects
Schröder, C.
Cognitive performance, behavioural and psychological symptoms, and circadian rhythm disturbances in Alzheimer’s disease patients treated with quetiapine or haloperidol
Schröter, A.
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*
Schubert, M. I.
Acute effects of corticosterone on BOLD signal: A pharmacological fMRI study in rats at 7 tesla
Schuld, A.
Immune-neuroendocrine interactions and their influence on the immune function in patients with depressive disorders
Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects – First results from a double-blind, placebocontrolled study
Influence of sleep deprivation on plasma ghrelin levels in healthy subjects
Elevation of liver enzyme levels during psychopharmacological treatment is associated with weight gain
Early prediction of changes in weight during six weeks of treatment with antidepressants
Body weight and the plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium
Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects
Schüle, C.
Influence of mirtazapine on salivary cortisol in depressed patients
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Gender influence on pharmacogenetic prediction of antidepressive efficacy
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
Schulz, C.
Auditory evoked P300 and treatment response to donepezil versus placebo in patients with Alzheimer’s disease
Schüssler, P.
Nocturnal ghrelin levels in normal controls – effects of gender
GHRH impairs sleep in normal females
Schütz, C. G.
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence
Schwab, S.
CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?
Schwaiger, M.
Interferon-alpha treatment and serotonergic dysfunction
Schwarz, C.
How do psychiatrists and schizophrenic patients assess treatment and outcome in outpatient care?
Subjective quality of life and treatment strategies in schizophrenia outpatient care
Cost effectiveness of different treatment strategies in schizophrenia outpatient care
Schwegler, H.
Different inhibitory mechanism in BALB-c and CPB/K mice using the prepulse inhibition paradigm – An animal model for schizophrenia?
Schwertfeger, N.
The effect of mirtazapine on cerebrovascular reactivity – A randomized, double-blind placebo-controlled study in healthy volunteers
Seemann, U.
How do psychiatrists and schizophrenic patients assess treatment and outcome in outpatient care?
Subjective quality of life and treatment strategies in schizophrenia outpatient care
Cost effectiveness of different treatment strategies in schizophrenia outpatient care
Seidl, S.
Leptin levels of alcohol abstainers and detoxification patients are not different
Seifritz, E.
GABAergic modulation during PSD, effects on microsleep and NonREM-sleep in volunteers and patients with major depression
Selig, F.
Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study
Cannabis and multiple substance abuse raise the serum concentrations of the neurotrophins NGF and BDNF in drug-naïve schizophrenic patients
Shah, N. J.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Alcohol-craving: Therapeutic effects using fMRI
Shapa, M.
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
Siegmund, A.
A new measure of the dopamine challenge by bromocriptine for testing personality
Siessmeier, T.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography
Sillaber, I.
Inbred mouse strains as models for the detection of genes relevant for the effects of antidepressants
Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress
Choosing the right black mice – a matter of particular importance!
Singer, A.
Hyperforin activates nonselective cation channels – A new mechanism of antidepressant activity
Singewald, N.
Magnesium-deficient diet alters depression and anxiety-related behavior in mice – Influence of desipramine and hypericum extract
Sinner, C.
Magnesium-deficient diet alters depression and anxiety-related behavior in mice – Influence of desipramine and hypericum extract
Sirén, A. L.
Neuroprotection in neuropsychiatric disease
Skerstupeit, M.
Time in depression and mania: Running fast or running slow? A computer based, controlled study of 93 depressed, manic and control subjects
Skipper, G.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Smesny, S.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Smirnov, A.
Neurochemical early and differential diagnosis of Alzheimer’s dementia
Smolka, M.
Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression
Sommer, M.
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses
Song, C.
Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression
Sonntag, A.
Evaluation of 1H-MRS as diagnostic marker for mild cognitive impairment and dementia
Spengler, D.
Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP
Sperling, W.
CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Craving differs with alcoholic beverages
Spernal, J.
Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression
Sperner-Unterweger, B.
Psychopharmacological treatment in cancer patients – Interactions between biological and psychological variables?
Spießl, H.
Subjective response to psychotropic drugs in psychiatric in-patients
Antidepressants from an internet-patients’ viewpoint
Rhabdomyolysis associated with olanzapine monotherapy – A case report
Spitzer, M.
Psychopharmacological treatment from the patients’ perspective. A computer-based automatic interview system
Stamm, T.
Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression
Stassen, H. H.
How to assess the onset of antidepressant effect: Empirical data on 2788 patients
Time course of response to antidepressant drug treatment: Are there gender differences?
Oligogenic approaches to modelling onset of action of antidepressants
A longitudinal syndrome-oriented approach to phenotypic heterogeneity
Stauch, R.
The medial geniculate nucleus and schizophrenia: A volumetric post-mortem study
Stawicki, S.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Stecker, G.
Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism
Steiger, A.
Nocturnal ghrelin levels in normal controls – effects of gender
Therapeutic sleep deprivation and magnesium: Modulators of the GABA/glutamate equilibrium
Ghrelin promotes slow-wave sleep in man
Gender differences in sleep endocrine regulation following administration of growth-hormone releasing hormone (GHRH) – relevance for the pathophysiology of major depression
GHRH impairs sleep in normal females
Steiner, B.
Neurotoxic mechanisms triggered by ß-amyloid: Role of oxidative stress, caspases and JNK pathway
Amyloid beta induces mitochondrial dysfunction in a dose-dependent manner
Steinlein, O. K.
Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome
Stengel, M.
Antidepressants increase CREB-phosphorylation via the 5-HT(1A)-receptor
Sterr, A.
EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Stoecker, T.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Stoeter, P.
Effective connectivity and pharmacological modulation in schizophrenia
Stohler, R.
Pharmacodynamic and -kinetic properties of heroin in maintenance treatment for opioid dependence
Storch, C.
Influence of circadian factors on behavioral and cognitive testing in mice
Ströhle, A.
Anxiolytic activity of atrial natriuretic peptide (ANP)
GABAergic effects of neuroactive steroids: Modulation of sleep and anxiety
Strom, T. M.
Evidence for genetic heterogeneity in Restless Legs Syndrome
Szafrański, T.
Polish version of Medication Adherence Rating Scale (MARS)
Smoking in schizophrenia –Relationship to psychopathology and side-effects
Szegedi, A.
How to assess the onset of antidepressant effect: Empirical data on 2788 patients
Time course of response to antidepressant drug treatment: Are there gender differences?
Oligogenic approaches to modelling onset of action of antidepressants
From mouse models to human behavior: Testing candidate genes for alcoholism
Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis
Tadic, A.
From mouse models to human behavior: Testing candidate genes for alcoholism
Talib, L. L.
Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment
Taracha, E.
Alanine aminopeptidase (AAP) activity in urine: A new marker of chronic alcohol abuse?
Combination of nephro- and hepatotoxicity of alcohol to improve diagnostic performance of markers of alcohol abuse
Tatsch, K.
Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate
Tavares Jr, H.
Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia
Teipel, S.
Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease
Teipel, S. J.
Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry
A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease
Neural representation of cognitive changes within the visual system in the AD brain
Theisen, F. M.
Genetic aspects of antipsychotic induced body weight change
Theuring, F.
Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors
Thron, A.
Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies
Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users
Thum, A.
Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression
Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results
Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm
Thürauf, N.
CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants
Toll, C.
A new measure of the dopamine challenge by bromocriptine for testing personality
Träber, F.
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence
Treffurth, Y.
Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P
Treiber, K.
Hyperforin activates nonselective cation channels – A new mechanism of antidepressant activity
Tremblay, P.
Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression
Trenkwalder, C.
Restaurative therapy for Parkinson’s disease
Evidence for genetic heterogeneity in Restless Legs Syndrome
Tsolakidou, A.
Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro
Tucha, O.
The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression
Turck, C. W.
Validation of a genetic mouse model for anxiety and comorbid depression
Analysis of cerebrospinal fluid of depressed patients
Uebelhack, R.
Saccadic eye movements and cognitive performance in schizophrenic patients treated with clozapine or flupentixol
Interferon-alpha treatment and serotonergic dysfunction
Cognitive function and psychomotor performance in schizophrenic patients
Ufer, S.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Differences in cortical activation by a working memory task after substitution of atypical neuroleptics
Uhr, M.
Ethyl-EPA and dexamethasone-resistance in therapy-refractory depression
Antidepressive drugs as substrates of P-glycoprotein at the blood brain barrier
Influence of sleep deprivation on plasma ghrelin levels in healthy subjects
Nocturnal ghrelin levels in normal controls – effects of gender
Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls
Ghrelin promotes slow-wave sleep in man
Results of routine CSF analysis of 1000 psychiatric patients
Analysis of cerebrospinal fluid of depressed patients
Ulferts, J.
Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients
Ullrich, H.
Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders?
Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study
Ulrich, S.
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Urbanek, C.
The role of myeloperoxidase and NADPH oxidase polymorphisms in clozapine-induced agranulocytosis
The NSAID rofecoxib reduces subjective cognitive impairment associated with ECT
Determination of predictors of twelve treatments (four weeks) outcome of titrated moderately suprathreshold (low dose) right unilateral (RUL) electroconvulsive therapy (ECT) in depression: a two year retrospective analysis
van Boemmel, F.
Interferon-alpha treatment and serotonergic dysfunction
van Calker, D.
Adenosinergic mechanisms in the brain: Potential targets for the treatment of mood disorders?
Mechanism of action of mood stabilizers
Varga, A.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Vedder, H.
Cytoimmunological changes and treatment response in major depression
Cytokines, the regulation of body weight and psychopharmacological treatment
Vernaleken, I.
Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography
Viviani, R.
Psychopharmacological treatment from the patients’ perspective. A computer-based automatic interview system
Voderholzer, U.
Transient narcolepsy-cataplexy-syndrome after discontinuation of the antidepressant venlafaxine
Vogel, M.
Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany
Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital
Vogel, T.
Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings
Volkmann, J.
Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease
von Kleinsorgen, M.
Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P
Vucurevic, G.
Effective connectivity and pharmacological modulation in schizophrenia
v Widdern, O.
CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?
Wacker, P.
Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex
Wagner, M.
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride
Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence
Wagner, P.
Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia
Long-term treatment with aripiprazole and its effects on negative and affective symptoms of schizophrenia
Efficacy of aripiprazole in the treatment of mania
Wagner, T.
The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment
Walcher, J.
Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease
Warnecke, M.
Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence
Weber, A.
Cytokines, the regulation of body weight and psychopharmacological treatment
Weber, E. H.
Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease
Weber, F.
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone
Weber, M.
Mutation analysis of the gene encoding the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome
Weber, M. M.
50 years of chlorpromazine – Serendipity or necessity
Weber, T.
Motor performance and motor induced brain activation are specifically influenced by schizophrenia as well as by typical and atypical neuroleptic treatment. A study combing fMRI and 3d Ultrasonic movement analyses
Wehrle, R.
Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study
Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study
Weikel, J. C.
Nocturnal ghrelin levels in normal controls – effects of gender
Ghrelin promotes slow-wave sleep in man
GHRH impairs sleep in normal females
Weinhold, N.
The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study
Weinmann, W.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Weiser, C.
Results of routine CSF analysis of 1000 psychiatric patients
Weißenbacher, P.
ENU-mouse mutagenesis screen: In search of animal models of psychiatric disorders
Refinement of inbred mouse strains as animal models for psychiatric disorders
Weller, L.
Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease
Welt, T.
Repetitive transcranial magnetic stimulation (rTMS) increases the release of dopamine in the nucleus accumbens of morphine-sensitized rats during drug-withdrawal
Consequences of chronic social stress on behavior, HPA-system regulation and AVP gene expression in the PVN, amygdala and hippocampus in mice – influence of CRH1-receptor antagonism
Modulation of CRH and AVP as a therapeutic strategy in anxiety disorders
Wendicke, K.
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Wenzel, A.
Genetic variants influencing retinal degeneration and neuroprotection in the eye
Wernicke, J.
Efficacy and safety of atomoxetine in adults with attention deficit/hyperactivity disorder
Westheide, J.
Second generation antipsychotics improve cognition in schizophrenic patients – Fact or artifact? Neurobiological mechanisms underlying clinical efficacy of atypical neuroleptics on negative symptoms and cognition: Olanzapine vs. Amisulpride
Sensorimotor gating and habituation of the startle reflex in schizophrenic patients treated with amisulpride or olanzapine compared to healthy controls
Wetter, T. C.
Different brain reactivity during phasic and tonic REM sleep: A simultaneous FMRI and EEG study
Processing of acoustic stimuli during NREM sleep: Results from a simultaneous fMRI and EEG study
Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study
Weyh, T.
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Whybrow, P. C.
Supraphysiological doses of L-thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study
Wicha, W.
Increase of matrix metalloproteinase-9 in peripheral blood of multiple sclerosis patients treated with high doses of methylprednisolone
Wichniak, A.
Ghrelin promotes slow-wave sleep in man
Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression
Wiedemann, K.
Gender effects in pharmacological relapse prevention of alcoholism
Megestrol attenuates hormonal response to CCK-4
Sex-specific differences in pain-induced facial muscle activation
The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study
Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide
Gender effects in depression: Influence of HPA axis activity and steroid synthesis inhibitors
Wiesbeck, G.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Wiesmann, M.
Treatment response in major depression is correlated with an increased concentration of the neuroplasticity marker S100B
Wiesmüller, M.
Differences in cortical activation by a working memory task after substitution of atypical neuroleptics
Wigger, A.
Molecular-genetic dissection of anxiety/depression: From HAB phenotype to functional SNP
Validation of a genetic mouse model for anxiety and comorbid depression
Wilhelm, J.
Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls
Willmroth, F.
Adenosinergic mechanisms in the brain: Potential targets for the treatment of mood disorders?
Mechanism of action of mood stabilizers
Wilms, S.
A psychoeducative-cognitive group setting for patients with schizophrenia: Making use of newly gained neuroplasticity
Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings
Wiltfang, J.
CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Neurochemical early and differential diagnosis of Alzheimer’s dementia
Winkelmann, J.
Evidence for genetic heterogeneity in Restless Legs Syndrome
Winterer, G.
Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing
Cortical signal-to-noise ratio: Prefrontal pathophysiology and genetics of schizophrenia – A two-center study in Bethesda (USA) and Berlin (Germany)
Wirtz, G.
Pharmaco-EEG-monitoring predicts antipsychotic efficacy of atypical antipsychotic drugs
Wirz-Justice, A.
Cognitive performance, behavioural and psychological symptoms, and circadian rhythm disturbances in Alzheimer’s disease patients treated with quetiapine or haloperidol
Wismann, B.
Effects of therapy of attention deficit hyperactivity disorder (ADHD) in the childhood with α-methylphenidate (MPH) on addiction diseases and psychiatric comorbidity
Witcher, J.
Pharmacologic properties of atomoxetine: a novel treatment for attention deficit/hyperactivity disorder
Witt, K.
Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease
Wittchen, H. U.
High cholesterol, triglycerides, and body-mass index in suicide attempters with major depression
Wochnik, G. M.
FKBP51 and FKBP52 differentially regulate corticosteroid receptors at distinct levels: Importance of the peptidylprolyl isomerase domain
Role of chaperones in signal transduction of the glucocorticoid receptor
Wodarz, N.
High-frequency transcranial magnetic stimulation decreases cigarette smoking
Wohlleben, G.
Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants
Wolf, J.
Aripiprazole, a novel antipsychotic. Report on a case series of 8 schizophrenic patients with emphasis on negative symptoms, libido and weight
Wolf, K.
Gender effects in pharmacological relapse prevention of alcoholism
Sex-specific differences in pain-induced facial muscle activation
The influence of olanzapine on facial expression of emotions in schizophrenia – An improved facial EMG study
Wolf, R.
Different inhibitory mechanism in BALB-c and CPB/K mice using the prepulse inhibition paradigm – An animal model for schizophrenia?
Wolfersdorf, M.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Leptin levels of alcohol abstainers and detoxification patients are not different
Wolźniak, A.
Polish version of Medication Adherence Rating Scale (MARS)
Smoking in schizophrenia –Relationship to psychopathology and side-effects
Wotjak, C. T.
The endocannabinoid system of the brain: A potential therapeutic target for the treatment of anxiety disorders in traumatised patients?
The roles of the endogenous cannabinoid system in learning and memory in mice
Wrase, J.
Relapse and gender specific activation of the striatum in alcohol dependent patients
Wurm, G.
Naturalistic follow-up study of pharmacologic treated patients with anxiety disorders
Wurst, F. M.
Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers
Leptin levels of alcohol abstainers and detoxification patients are not different
Wurst, W.
Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress
Wuttke, H.
CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants
Xu, K.
Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing
Yacubian, J.
Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia
Yassouridis, A.
Influence of sleep deprivation on plasma ghrelin levels in healthy subjects
Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro
Yavuz, A.
Acupuncture in patients with minor depressive episodes and generalized anxiety. Results of an experimental study
Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone
Yehuda, R.
Increased 24-hour urinary cortisol and decreased endocrine and sleep response to metyrapone in posttraumatic stress disorder
Zaudig, M.
Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*
Zernig, G.
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“
Zetzsche, T.
Structural changes of the hippocampus and the amygdala in patients with major depression and healthy controls during a one year follow-up
Possible changes of hippocampus and amygdala in borderline personality disorder: A structural magnetic resonance imaging study
Combined dopamine transporter and D2-receptor imaging in schizophrenia: Implications for atypical neuroleptics
Ziegenhorn, A. A.
Clonidine for hypernoradrenergic symptoms In patients with borderline personality disorder
Zieglgänsberger, W.
Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor
α-thujone reduces 5-HT3 receptor activity by an effect on the agonist-induced desensitization
Zietz, B.
Risk of diabetes and schizophrenia
Zihl, J.
Neuropsychological deficits and long-term outcomes in patients with affective disorders
Zill, P.
Different protein expression levels after antidepressant treatment on EBV cells of depressed patients
Gender influence on pharmacogenetic prediction of antidepressive efficacy
Zilles, K.
Alcohol-craving: Therapeutic effects using fMRI
Zimbelmann, M.
Validation of a genetic mouse model for anxiety and comorbid depression
Zimmer, A.
New insights into the role of the opioid system as mediator of drug addiction by studies in transgenic mice
Zimmermann, S.
Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress
Zobel, A.
CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?
Zowe, M.
Cortical excitability in neuroleptic-naive first-episode schizophrenic patients
Zwanzger, P.
Effects of alprazolam on cholecystokinin-tetrapeptide (CCK-4) induced panic and hypothalamic-pituitary-adrenal (HPA) axis activity
Evaluation of a novel sham condition for repetitive transcranial magnetic stimulation (rTMS)
Gender influence on pharmacogenetic prediction of antidepressive efficacy
Zwisler, R.
Antidepressants from an internet-patients’ viewpoint